pentobarbital will lessen the extent or effect of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Use of different therapies is strongly advisable when linagliptin will be to be administered with a CYP3A4 inducerpentobarbital will decrease the level or result of atogepant by influencing hepatic/intestinal en